1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow IV Ketamine: new trials by email Literature Review of IV Ketamine trials Research Report on IV Ketamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment IV Ketamine - Depression, Mild Cognitive Impairment | Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 15 | 2024-11-01 | 2025-01-29 |
| Ketamine Treatment for PTSD and MDD in TBI IV ketamine, Midazolam - PTSD, Post Traumatic Stress Disorder, Major Depressive Disorder | Phase 2 | Not yet recruiting | Minneapolis Veterans Affairs Medical Center | 40 | 2024-03-01 | 2024-01-29 |
| Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation IN Ketodex (D4K2), IN Ketodex (D3K3), IN Ketodex (D2K4) - Fracture, Dislocation | Phase 2 / Phase 3 | Recruiting | Naveen Poonai | 400 | 2020-03-11 | 2024-11-05 |
Depression (2) · Brain Injuries, Traumatic (1) · Cognitive Dysfunction (1) · Combat Disorders (1) · Depressive Disorder, Major (1) · Fractures, Bone (1) · Joint Dislocations (1) · Stress Disorders, Post-Traumatic (1)
Icahn School of Medicine at Mount Sinai (1) · Minneapolis Veterans Affairs Medical Center (1) · Naveen Poonai (1)
United States (2) · Canada (1)
Naveen Poonai, MD (1) · Rachel Fremont, MD, PhD (1)